Hera S.p.A. : After the accumulation, an upward acceleration ?
| Entry price | Target | Stop-loss | Potential |
|---|
|
€0 |
€3.8 |
€3.1 |
+∞% |
|---|
From a horizontal accumulation phase, the timing seems good to buy shares in Hera and to get ahead of a break-out on the upside of the congestion area.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
● The share is getting closer to its long-term support in weekly data, at EUR 3.14, which offers good timing for buyers.
● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● Technically, the stock approaches a strong medium-term resistance at EUR 3.38.
● The group shows a rather high level of debt in proportion to its EBITDA.
● The technical configuration over the long term remains negative on the weekly chart below the resistance level at 3.76 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
HERA S.P.A. 
